Product Code: TMRGL56190
The report provides revenue of the global point-of-care coagulation testing devices market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global point-of-care coagulation testing devices market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the point-of-care coagulation testing devices market.
The report delves into the competitive landscape of the global point-of-care coagulation testing devices market. Key players operating in the global point-of-care coagulation testing devices market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global point-of-care coagulation testing devices market profiled in this report.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Point-of-Care Coagulation Testing Devices Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Segment Definition
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Point-of-Care Coagulation Testing Devices Market Analysis and Forecast, 2017-2031
- 4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
- 5.1. Technological Advancements
- 5.2. Key Mergers & Acquisitions
- 5.3. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)
6. Global Point-of-Care Coagulation Testing Devices Market Analysis and Forecast, by Product
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Product, 2017-2031
- 6.3.1. Instruments / Analyzers
- 6.3.2. Consumables & Accessories
- 6.4. Market Attractiveness Analysis, by Product
7. Global Point-of-Care Coagulation Testing Devices Market Analysis and Forecast, by Method
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by Method, 2017-2031
- 7.3.1. PT/INR
- 7.3.2. Viscoelastic Coagulation Monitoring
- 7.3.3. Others (ACT, aPTT, etc.)
- 7.4. Market Attractiveness Analysis, by Method
8. Global Point-of-Care Coagulation Testing Devices Market Analysis and Forecast, by End-user
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast, by End-user, 2017-2031
- 8.3.1. Hospitals
- 8.3.2. Diagnostic Laboratories
- 8.3.3. Clinics
- 8.4. Market Attractiveness Analysis, by End-user
9. Global Point-of-Care Coagulation Testing Devices Market Analysis and Forecast, by Region
- 9.1. Key Findings
- 9.2. Market Value Forecast, by Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
- 9.3. Market Attractiveness Analysis, by Region
10. North America Point-of-Care Coagulation Testing Devices Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Market Value Forecast, by Product, 2017-2031
- 10.2.1. Instruments / Analyzers
- 10.2.2. Consumables & Accessories
- 10.3. Market Value Forecast, by Method, 2017-2031
- 10.3.1. PT/INR
- 10.3.2. Viscoelastic Coagulation Monitoring
- 10.3.3. Others (ACT, aPTT, etc.)
11. Europe Point-of-Care Coagulation Testing Devices Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast, by Product, 2017-2031
- 11.2.1. Instruments / Analyzers
- 11.2.2. Consumables & Accessories
- 11.3. Market Value Forecast, by Method, 2017-2031
- 11.3.1. PT/INR
- 11.3.2. Viscoelastic Coagulation Monitoring
- 11.3.3. Others (ACT, aPTT, etc.)
- 11.4. Market Value Forecast, by End-user, 2017-2031
- 11.4.1. Hospitals
- 11.4.2. Diagnostic Laboratories
- 11.4.3. Clinics
- 11.4.4. Others
- 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Spain
- 11.5.5. Italy
- 11.5.6. Rest of Europe
- 11.6. Market Attractiveness Analysis
- 11.6.1. By Product
- 11.6.2. By Method
- 11.6.3. By End-user
- 11.6.4. By Country/Sub-region
12. Asia Pacific Point-of-Care Coagulation Testing Devices Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast, by Product, 2017-2031
- 12.2.1. Instruments / Analyzers
- 12.2.2. Consumables & Accessories
- 12.3. Market Value Forecast, by Method, 2017-2031
- 12.3.1. PT/INR
- 12.3.2. Viscoelastic Coagulation Monitoring
- 12.3.3. Others (ACT, aPTT, etc.)
- 12.4. Market Value Forecast, by End-user, 2017-2031
- 12.4.1. Hospitals
- 12.4.2. Diagnostic Laboratories
- 12.4.3. Clinics
- 12.4.4. Others
- 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
- 12.6. Market Attractiveness Analysis
- 12.6.1. By Product
- 12.6.2. By Method
- 12.6.3. By End-user
- 12.6.4. By Country/Sub-region
13. Latin America Point-of-Care Coagulation Testing Devices Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Product, 2017-2031
- 13.2.1. Instruments / Analyzers
- 13.2.2. Consumables & Accessories
- 13.3. Market Value Forecast, by Method, 2017-2031
- 13.3.1. PT/INR
- 13.3.2. Viscoelastic Coagulation Monitoring
- 13.3.3. Others (ACT, aPTT, etc.)
- 13.4. Market Value Forecast, by End-user, 2017-2031
- 13.4.1. Hospitals
- 13.4.2. Diagnostic Laboratories
- 13.4.3. Clinics
- 13.4.4. Others
- 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
- 13.6. Market Attractiveness Analysis
- 13.6.1. By Product
- 13.6.2. By Method
- 13.6.3. By End-user
- 13.6.4. By Country/Sub-region
14. Middle East & Africa Point-of-Care Coagulation Testing Devices Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Market Value Forecast, by Product, 2017-2031
- 14.2.1. Instruments / Analyzers
- 14.2.2. Consumables & Accessories
- 14.3. Market Value Forecast, by Method, 2017-2031
- 14.3.1. PT/INR
- 14.3.2. Viscoelastic Coagulation Monitoring
- 14.3.3. Others (ACT, aPTT, etc.)
- 14.4. Market Value Forecast, by End-user, 2017-2031
- 14.4.1. Hospitals
- 14.4.2. Diagnostic Laboratories
- 14.4.3. Clinics
- 14.4.4. Others
- 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
- 14.6. Market Attractiveness Analysis
- 14.6.1. By Product
- 14.6.2. By Method
- 14.6.3. By End-user
- 14.6.4. By Country/Sub-region
15. Competition Landscape
- 15.1. Market Player - Competition Matrix (by tier and size of companies)
- 15.2. Company Profiles
- 15.2.1. F. Hoffmann-La Roche AG
- 15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.1.2. Product Portfolio
- 15.2.1.3. SWOT Analysis
- 15.2.1.4. Strategic Overview
- 15.2.2. Abbott Laboratories
- 15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.2.2. Product Portfolio
- 15.2.2.3. Financial Overview
- 15.2.2.4. SWOT Analysis
- 15.2.2.5. Strategic Overview
- 15.2.3. Siemens Healthineers
- 15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.3.2. Product Portfolio
- 15.2.3.3. SWOT Analysis
- 15.2.3.4. Strategic Overview
- 15.2.4. Medtronic plc
- 15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.4.2. Product Portfolio
- 15.2.4.3. Financial Overview
- 15.2.4.4. SWOT Analysis
- 15.2.4.5. Strategic Overview
- 15.2.5. Haemonetics Corporation
- 15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.5.2. Product Portfolio
- 15.2.5.3. Financial Overview
- 15.2.5.4. SWOT Analysis
- 15.2.5.5. Strategic Overview
- 15.2.6. HemoSonics, LLC
- 15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.6.2. Product Portfolio
- 15.2.6.3. SWOT Analysis
- 15.2.6.4. Strategic Overview
- 15.2.7. Micropoint Bioscience, Inc.
- 15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.7.2. Product Portfolio
- 15.2.7.3. Financial Overview
- 15.2.7.4. SWOT Analysis
- 15.2.7.5. Strategic Overview
- 15.2.8. Werfen
- 15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.8.2. Product Portfolio
- 15.2.8.3. Financial Overview
- 15.2.8.4. SWOT Analysis
- 15.2.8.5. Strategic Overview
- 15.2.9. Sienco, Inc.
- 15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.9.2. Product Portfolio
- 15.2.9.3. SWOT Analysis
- 15.2.9.4. Strategic Overview
- 15.2.10. Koninklijke Philips N.V.
- 15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.2.10.2. Product Portfolio
- 15.2.10.3. SWOT Analysis
- 15.2.10.4. Strategic Overview